Rapid or unsupervised discontinuation of tirzepatide carries a significant risk of weight regain
The best option depends on several factors, including health history, metabolic health, medication tolerance, side effect response, and long-term weight loss goals
Plus, a 2022 study on tirzepatide found that nearly 5%--6% of participants taking the drug (5 mg, 10 mg, and 15 mg) experienced hair loss or alopecia
All materials needed will be provided in the prescription
Information is collected during routine clinical care, and AEs are likely underreported relative to protocolized, prospective AE ascertainment in clinical trials
How to Inject Using a Vial and Syringe If you are using a personalized program that includes compounded tirzepatide , your medication may arrive in a multi-dose vial